Skip to content

Quality of life (QOL) assessment in the care of individual cancer patients

Quality of life (QOL) assessment in the care of individual cancer patients: a randomised interventional trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77737914
Enrollment
220
Registered
2010-04-29
Start date
2004-03-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: National Cancer Research Network

Interventions

After the baseline visit, patients in the intervention group will be asked to complete the EORTC QLQ-C30 and HADS on a touch-screen (TS) computer while waiting to see a doctor. This will be done over

Sponsors

University of Leeds (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed or relapsed patients with cancer starting chemotherapy or multimodality treatment 2. Expected to attend the clinic at least 3times after the initial baseline visit; 3. Able and willing to give informed consent 4. Not taking part in other QL studies run by the Unit 5. Able to read and understand English 6. Not exhibiting overt psychopathology or serious cognitive dysfunction which would impede their being able to take part in the study 7. Either sex, lower age limit of 18 years

Exclusion criteria

Exclusion criteria: Does not meet the exclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Content of communication, measured at baseline and for a further three visits 2. Functional Assessment of Cancer Therapy General Scale (FACT-G), measured at baseline and at the end of the study

Secondary

MeasureTime frame
1. Other process measures (symptomatic drugs, tests, referrals), collected at baseline and for the next three visits 2. Patient-related outcomes (continuity of care and patient satisfaction), collected at baseline and at the end of the study 3. Descriptive information on patient views and attitudes regarding regular QOL data collection, collected at the end of the study

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026